EUVIMEDEUVIMED entdecken
Open Access

Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition

Yuna Roh, Jinhyeon Choi, Jin-Seong Hwang, Yeo-Jin Lee, Taesang Son, Sarang Kim, Nayeon Gu, Hyun Seung Ban, Eunsun Jung, Jang-Seong Kim, Tae-Su Han

Journal of Microbiology and Biotechnology · 13.03.2026 · 36

DOI: 10.4014/jmb.2512.12029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 13.03.2026. Verfasst von Yuna Roh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Melanoma, Carrier Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning, Korean Fund for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledMelanomaCarrier ProteinsHumansCell ProliferationSTAT3 Transcription FactorCell Line, TumorGene Expression Regulation, NeoplasticCell MovementMetabolic ReprogrammingGene Expression ProfilingSignal TransductionGlycolysis

Stichwörter der Autor:innen

GPR161MelanomaSTAT3TXNIP

Substanzen

Receptors, G-Protein-CoupledTXNIP protein, humanCarrier ProteinsSTAT3 Transcription FactorSTAT3 protein, human

Autor:innen und Institutionen

  • Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
  • University of Science and Technology (UST), Daejeon 34141, Republic of Korea.
  • Department of Biology Education, Seoul National University, Seoul 08826, Republic of Korea.
  • Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 08308, Republic of Korea.
  • School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning
  • Korean Fund for Regenerative Medicine
  • Ministry of Science and ICT
  • Ministry of Health and Welfare
  • Korea Research Institute of Bioscience and Biotechnology

Zitieren

APA

Roh, Y., Choi, J., Hwang, J. S., Lee, Y. J., Son, T., Kim, S., Gu, N., Ban, H. S., Jung, E., Kim, J. S., & Han, T. S. (2026). Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition. Journal of Microbiology and Biotechnology, 36. https://doi.org/10.4014/jmb.2512.12029

Vancouver

Roh Y, Choi J, Hwang JS, Lee YJ, Son T, Kim S, et al. Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition. Journal of Microbiology and Biotechnology. 2026;36. doi:10.4014/jmb.2512.12029

BibTeX
@article{Roh2026,
  author = {Roh, Yuna and Choi, Jinhyeon and Hwang, Jin-Seong and Lee, Yeo-Jin and Son, Taesang and Kim, Sarang and Gu, Nayeon and Ban, Hyun Seung and Jung, Eunsun and Kim, Jang-Seong and Han, Tae-Su},
  title = {Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2026},
  volume = {36},
  doi = {10.4014/jmb.2512.12029}
}
Kostenlos starten →